Abnormal diastolic function underlies the different beneficial effects of cardiac resynchronization therapy on ischemic and non-ischemic cardiomyopathy. Clinics, [S. l.], v. 72, n. 7, p. 432–437, 2017. DOI: 10.6061/clinics/2017(07)08. Disponível em: https://revistas.usp.br/clinics/article/view/135269.. Acesso em: 28 apr. 2024.